Patient Guide: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 156 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06499285
Status: 🟢 Enrolling Now
Condition: Myelodysplastic Syndromes
Phase: PHASE3

Where You Can Participate

This study is available at 156 locations across the country.

Top locations include:
  • • Duarte, California
  • • Glendale, California
  • • La Jolla, California
  • • And 153 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions - Join Clinical Trial NCTNCT06499285

How to Join This Clinical Trial - NCTNCT06499285

Learn how to participate in this PHASE3 trial studying an investigational therapy for Myelodysplastic Syndromes. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myelodysplastic Syndromes. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myelodysplastic Syndromes
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06499285 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 156 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91206 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Peoria, Illinois 61645 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Columbia, Maryland 21044 - United States

Status: NOT_YET_RECRUITING

And 146 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Myelodysplastic Syndromes:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships